Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision tag: v3.4.2. The government funding lapse notice was removed, and no study-specific content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice about potential delays and directs users to opm.gov for status updates, and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a glossary toggle. Footer text was updated to show 'Last Update Submitted that Met QC Criteria' with capitalization changes, and it adds 'No FEAR Act Data' and 'Revision: v3.4.0' while the previous 'No FEAR Act data' wording is removed.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor page revision: Revision v3.3.4 was added and v3.3.3 removed. No changes to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing Revision: v3.3.2, as well as deleting the HHS Vulnerability Disclosure link. The study details page content remains unchanged.SummaryDifference0.1%

- Check92 days agoChange DetectedThe change represents a minor revision update from v3.2.0 to v3.3.2 with no visible edits to study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.